Deep 6 AI Platform
AI-powered clinical trial patient recruitment and feasibility platform
Company profile
Company profile
Deep 6 AI is a healthcare technology company that specializes in accelerating clinical trial patient recruitment through artificial intelligence. The company's platform uses advanced AI and natural language processing to analyze electronic health records (EHRs) in real-time, enabling healthcare organizations, research institutions, and pharmaceutical companies to identify eligible patients for clinical trials with unprecedented speed and accuracy. By automating the traditionally manual and time-consuming process of patient screening, Deep 6 AI helps reduce recruitment timelines from months to days while improving the quality of patient matches. The platform integrates with existing EHR systems to search structured and unstructured clinical data, applying complex inclusion and exclusion criteria across large patient populations. Deep 6 AI's technology addresses one of the most significant bottlenecks in clinical research—patient recruitment—which is responsible for delays in bringing new treatments to market. The company serves health systems, academic medical centers, pharmaceutical companies, and contract research organizations, helping them accelerate research timelines, reduce costs, and ultimately bring life-saving therapies to patients faster.
Company description Deep 6 AI official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Cloud Saas deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered clinical trial patient recruitment and feasibility platform
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
International journal of chronic obstructive pulmonary disease · Jan 1, 2025
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Reduces patient screening from months to days
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Deep 6 AI's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.